Technology | Magnetic Resonance Imaging (MRI) | August 04, 2017

GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance

MRI system designed in collaboration with the NFL and research institutions for enhanced clinical performance with additional research-focused capabilities

GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance

August 4, 2017 — GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available for sale in the United States. Signa Premier is the result of a four-year collaboration with the National Football League (NFL) and research institutions around the world working to design new imaging tools, particularly to aid researchers in the detection of biomarkers for the potential diagnosis of mild traumatic brain injury (TBI). GE said the system delivers a new level of clinical performance with additional research-focused capabilities, especially for neurology and oncology research.

Signa Premier features: 

  • GE Healthcare’s latest, short-bore, high-homogeneity 3.0T superconductive magnet;
  • The most powerful gradient system GE Healthcare has ever developed for a wide bore 3.0T system, according to the company; and
  • A new, digital RF transmit and receive architecture.

Clinical and research applications benefit from this high-performance hardware as well as machine learning software that includes cloud analytics. The system is powered by SuperG gradient technology. The SuperG gradient coil introduces high performance and stability, which is designed to deliver the performance of ultra-high-performance, research-class 60 centimeter MRI system in a 70 centimeter bore.

The RF technology of Signa Premier provides 146 independent receiver channels that allow the simultaneous acquisition of patient data from multiple high channel-density surface coils for faster scanning, higher image quality and overall enhanced clinical performance compared to previous-generation GE MRI systems.

The 48-channel Head Coil delivers improved clinical performance compared to previous GE MRI systems for virtually every patient. A fit-adaptable design addresses 99.99 percent of the population— including patients with extremely large heads and short necks—while preserving high signal-to-noise ratio (SNR) and high image quality. Additionally, Signa Premier can perform a routine fast brain examination in under five minutes by leveraging HyperSense, a new speed scanning tool, delivering up to eight times faster scanning than previous-generation GE MRI systems, which is part of the HyperWorks application suite.

For more information: www.gehealthcare.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...